Recombinant cow CXCL11 Protein
Beta LifeScience
SKU/CAT #: BLA-2216P
Recombinant cow CXCL11 Protein
Beta LifeScience
SKU/CAT #: BLA-2216P
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Host Species | Cow |
Synonym | b R1 b-R1 Beta-R1 betaR1 C-X-C motif chemokine 11 Chemokine (C-X-C motif) ligand 11 Chemokine C-X-C motif ligand 11 CXC11 CXCL11 CXL11_HUMAN H174 I TAC I-TAC Interferon gamma inducible protein 9 Interferon gamma-inducible protein 9 Interferon inducible T cell alpha chemoattractant Interferon-inducible T-cell a chemoattractant I-TAC Interferon-inducible T-cell alpha chemoattractant IP 9 IP-9 IP9 ITAC MGC102770 SCYB11 SCYB9B Small inducible cytokine B11 Small inducible cytokine subfamily B (Cys-X-Cys) member 11 Small inducible cytokine subfamily B (Cys-X-Cys) member 9B Small inducible cytokine subfamily B, member 11 Small inducible cytokine subfamily B, member 9B Small-inducible cytokine B11 |
Description | Recombinant cow CXCL11 Protein was expressed in Saccharomyces cerevisiae. It is a Full length protein |
Source | Saccharomyces cerevisiae |
AA Sequence | FPMFKGGRCL CIGPGVKAVK VADIEKVSII YPTNNCDKTE VIITLKTHKG QRCLNPKAKQ AKAIIKKVQR KNSEKYKNI |
Purity | >95% purity as determined by SDS-PAGE |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method |
Bioactivity | The biological activity of ab88003 was determined in a chemotaxis assay using a Boyden chamber with bovine PBMC following initial culture with IL2. Bioactivity is typically detected at 25 ng/mL. |
Formulation | Lyophilised |
Stability | The recombinant protein samples are stable for up to 12 months at -80°C |
Reconstitution | See related COA |
Unit Definition | For Research Use Only |
Storage Buffer | Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycle. |